Scarica l'app Stockscreener
0.8517
7.25%
-0.0666
Dopo l'orario di chiusura:
.80
-0.0517
-6.07%
Precedente Chiudi:
$0.9183
Aprire:
$0.869
Volume 24 ore:
280.65K
Relative Volume:
0.10
Capitalizzazione di mercato:
$1.75M
Reddito:
$4.76M
Utile/perdita netta:
$-9.32M
Rapporto P/E:
-0.1489
EPS:
-5.7182
Flusso di cassa netto:
$-4.25M
1 W Prestazione:
-7.42%
1M Prestazione:
-10.87%
6M Prestazione:
-76.60%
1 anno Prestazione:
-82.90%
Intervallo 1D:
$0.7651
$0.8868
Intervallo di 1 settimana:
$0.7651
$1.94
Portata 52W:
$0.7651
$6.71
Arcadia Biosciences Inc Stock (RKDA) Company Profile
Nome
Arcadia Biosciences Inc
Settore
Industria
Telefono
214-974-8921
Indirizzo
5956 SHERRY LANE, DALLAS, CA
Compare RKDA vs JBS, KHC, GIS, HRL, MKC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RKDA
Arcadia Biosciences Inc
|
0.8517 | 1.89M | 4.76M | -9.32M | -4.25M | -5.7182 |
JBS
Jbs Nv
|
12.30 | 40.09B | 88.25B | 1.91B | -681.64M | 1.6761 |
KHC
Kraft Heinz Co
|
23.80 | 28.45B | 24.99B | -5.76B | 3.95B | -4.863 |
GIS
General Mills Inc
|
34.40 | 18.29B | 18.37B | 2.22B | 1.65B | 4.0676 |
HRL
Hormel Foods Corp
|
24.65 | 13.53B | 12.22B | 466.64M | 692.94M | 0.8477 |
MKC
Mccormick Co Inc
|
47.19 | 12.87B | 7.11B | 1.65B | 680.40M | 6.1005 |
Arcadia Biosciences Inc Stock (RKDA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2020-08-17 | Reiterato | H.C. Wainwright | Buy |
| 2017-05-12 | Downgrade | Piper Jaffray | Overweight → Neutral |
| 2015-06-09 | Iniziato | Credit Suisse | Outperform |
| 2015-06-09 | Iniziato | Piper Jaffray | Overweight |
Arcadia Biosciences Inc Borsa (RKDA) Ultime notizie
Arcadia Biosciences Announces $4 Million Private Placement - TipRanks
Arcadia Biosciences Raises ~$4 Million in Private Placement of Pre-Funded Warrants and Options - TradingView
Arcadia Biosciences (RKDA) completes $4M private placement with warrants and options - Stock Titan
RKDA Q3 2025 Earnings: Surprise Profit Beats Estimates by Wide MarginDownward Estimate Revision - newsline.com
Arcadia Biosciences closes $4 million private placement - Investing.com
Arcadia Biosciences closes $4 million private placement By Investing.com - Investing.com South Africa
Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules - The Manila Times
Arcadia Biosciences, Inc. Closes $4 Million Private Placement of Common Stock and Preferred Investment Options - Quiver Quantitative
Arcadia Biosciences raises $4M in at-the-market stock deal - Stock Titan
Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced ... - Caledonian Record
Arcadia Biosciences (RKDA) Announces Closing of $4 Million - GlobeNewswire
MSN Money - MSN
RKDA News | ARCADIA BIOSCIENCES INC (NASDAQ:RKDA) - ChartMill
Arcadia Biosciences Raises $4 Million in Private Placement - marketscreener.com
What Does Arcadia Biosciences' Latest $4 Million Private Placement Entail - Kavout
Wellness products maker Arcadia Biosciences lines up $4M in funding - Stock Titan
Arcadia Biosciences (RKDA) Secures Funding with New Share Agreem - GuruFocus
Arcadia Biosciences, Inc. Announces Private Placement of Common Stock and Preferred Investment Options to Raise Approximately $4 Million - Quiver Quantitative
Arcadia Biosciences raises $4 million in private placement - Investing.com
Arcadia Biosciences (RKDA) Announces $4 Million Private Placement Priced At-The-Market Under ... - Caledonian Record
Arcadia Biosciences (RKDA) Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules - GlobeNewswire Inc.
Arcadia Biosciences, Inc. announced that it has received $3.999613 million in funding - marketscreener.com
Arcadia Biosciences (RKDA) jumps 44.5% amid heavy volume, with no clear new headline catalyst - Quiver Quantitative
RKDA Stock Whipsaws As Traders Focus On Cash, Chart - StocksToTrade
RKDA Stock Slides As Volatile Chart Tests Day Traders - timothysykes.com
RKDA Q3 2025 Earnings: EPS Surge Beats Estimates Amid No Revenue DisclosureEarnings Volatility Report - newsline.com
Arcadia Biosciences (RKDA) Slips 1.89% as Stock Tests Key Support Near $0.86Golden Cross - newsline.com
RKDA Q3 2025 Earnings: Positive EPS Surprise Amidst Revenue ChallengesCore Business Growth - newsline.com
RKDA Stock Price, Quote & Chart - ChartMill
RKDA Q3 2025 Earnings: Surprise Profitability Without Reported RevenueEarnings Revision Upgrade - newsline.com
Arcadia Biosciences (RKDA) Slides to $0.95: Support Test on the HorizonIV Percentile - newsline.com
Arcadia Biosciences Stock Under $1: Why RKDA’s Next Move Hinges on Zola and Cash - Bez Kabli
Arcadia Biosciences (RKDA) Shows Modest Uptick Amid Consolidation Near Key LevelsChange of Character - newsline.com
Arcadia Biosciences (RKDA) Q3 2025 Profit Surges Past Wall Street TargetsFinancial Health Score - The Legal Advocate
RKDA Q3 2025 Earnings: Stunning EPS Surprise Driven by Non-Recurring Items, Stock RalliesProduct Revenue Analysis - newsline.com
RKDA Q3 2025 Earnings: Arcadia Biosciences Posts Surprise Profit as EPS Smashes EstimatesRising Community Picks - Newser
RKDA Stock Pops On Volume As Traders Hunt Volatility - StocksToTrade
RKDA Stock Slides As Traders Weigh Cash Runway And Charts - timothysykes.com
Arcadia Biosciences (RKDA) Rallies +27.91% as Bulls Target $1.29 2026-05-20Technical Analysis - newsline.com
Arcadia Biosciences (RKDA) Q3 2025 Beat: Revenue $N/A, EPS Exceeds by SignificantDividend Growth Analysis - The Legal Advocate
Armistice Capital (RKDA) reports 159,390 shares, 7.75% stake - Stock Titan
Arcadia Biosciences (RKDA) Delivers Q3 2025 Beat — EPS $0.62 vs $-0.55 ExpectedRevenue Guidance - newser.com
Arcadia Biosciences: Q1 Earnings Snapshot - KTVB
Arcadia Biosciences (RKDA) Announces First Quarter 2026 Financial Results and Business Highlights - The Manila Times
RKDA: Zola volumes rose 18% but net loss widened to $4.4M on lower revenue and one-time charges - TradingView
Arcadia Biosciences | 10-Q: Q1 2026 Earnings Report - Moomoo
Arcadia Biosciences (RKDA) Q1 2026 loss deepens amid going concern risk - Stock Titan
Arcadia Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
[8-K] Arcadia Biosciences, Inc. Reports Material Event - Stock Titan
Arcadia Biosciences stock (US03020Q1058): Recent price volatility draws attention - AD HOC NEWS
TradingKey - TradingKey
Arcadia Biosciences Inc Azioni (RKDA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.17%
1.67%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):